Krsnaa Diagnostics Limited (NSE:KRSNAA)
539.80
+5.50 (1.03%)
Jun 15, 2026, 3:30 PM IST
Krsnaa Diagnostics Revenue
In the fiscal year ending March 31, 2026, Krsnaa Diagnostics had annual revenue of 7.99B INR with 11.37% growth. Krsnaa Diagnostics had revenue of 1.93B in the quarter ending March 31, 2026, with 3.51% growth.
Revenue
7.99B
Revenue Growth
+11.37%
P/S Ratio
2.17
Revenue / Employee
2.30M
Employees
3,471
Market Cap
17.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.99B | 815.66M | 11.37% |
| Mar 31, 2025 | 7.17B | 975.27M | 15.74% |
| Mar 31, 2024 | 6.20B | 1.33B | 27.20% |
| Mar 31, 2023 | 4.87B | 316.73M | 6.95% |
| Mar 31, 2022 | 4.55B | 589.94M | 14.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Shalby | 11.41B |
| Windlas Biotech | 9.04B |
| Ind-Swift Laboratories | 6.88B |
| Beta Drugs | 3.85B |
Krsnaa Diagnostics News
- 20 days ago - Krsnaa Diagnostics Transcript: Q4 25/26 - Transcripts
- 20 days ago - Krsnaa Diagnostics Quarterly report: Q4 2026 - Filings
- 20 days ago - Krsnaa Diagnostics Slides: Q4 2026 - Filings
- 4 months ago - Krsnaa Diagnostics Transcript: Q3 25/26 - Transcripts
- 4 months ago - Krsnaa Diagnostics Quarterly report: Q3 2026 - Filings
- 4 months ago - Krsnaa Diagnostics Slides: Q3 2026 - Filings
- 4 months ago - Why are Krsnaa Diagnostics shares down 3% today? Explained - Business Upturn
- 6 months ago - Krsnaa Diagnostics approves Rs 430 crore fundraise via NCDs - Business Upturn